Mizuho Securities analyst Ann Hynes reiterated a Buy rating and $120.00 price target on CVS Health (NYSE: CVS) following Q3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View

UPDATE: Cano Health (CANO) Trades at High as CVS, Humana Talk M&ANovember 2, 2022 9:53 AM CVS Health (CVS) Edges Higher on Q3 Beat, Raised FY ForecastNovember 2, 2022 8:52 AM CVS Health, AMD, Yum Brands Rise Premarket; Estée Lauder, Airbnb FallNovember 2, 2022 8:16 AM Dow Futures Fall 30 Pts; Caution Ahead of Fed AnnouncementNovember 2, 2022 7:40 AM CVS looks to 2023 after opioids settlement, Medicare rating declineNovember 2, 2022 6:37 AM Form 10-Q CVS HEALTH Corp For: Sep 30November 2, 2022 6:37 AM Form 8-K CVS HEALTH Corp For: Nov 02November 2, 2022 6:34 AM CVS Health (CVS) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY22 EPS GuidanceNovember 2, 2022 6:34 AM CVS HEALTH REPORTS THIRD QUARTER RESULTSNovember 2, 2022 6:30 AM CVS Health (CVS) Reaches Global Opioid Settlement, Will Pay $5B Over 10 YearsNovember 2, 2022 6:25 AM CVS Health reaches agreement in principle for global opioid settlementNovember 2, 2022 6:25 AM Fed Statement, Qualcomm, CVS Health Earnings: 3 Things to WatchNovember 1, 2022 4:26 PM